These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22490187)

  • 21. Efficacy of keishibukuryogan for hot flashes in prostate cancer patients receiving androgen deprivation therapy: a sub-analysis focusing on hormonal and cytokine levels.
    Shigehara K; Izumi K; Nakashima K; Kawaguchi S; Nohara T; Kadono Y; Mizokami A
    Transl Androl Urol; 2023 Aug; 12(8):1273-1282. PubMed ID: 37680217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of proinflammatory cytokines and selected bioelements in perimenopausal women with regard to body mass index.
    Cybulska AM; Rachubińska K; Szkup M; Schneider-Matyka D; Baranowska-Bosiacka I; Chlubek D; Lubkowska A; Panczyk M; Sołek-Pastuszka J; Grochans E
    Aging (Albany NY); 2021 Dec; 13(23):25025-25037. PubMed ID: 34890370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies.
    Nagata H; Nozaki M; Nakano H
    J Obstet Gynaecol Res; 2005 Apr; 31(2):107-14. PubMed ID: 15771635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal associations of hot flashes and depression in the transition to menopause.
    Freeman EW; Sammel MD; Lin H
    Menopause; 2009; 16(4):728-34. PubMed ID: 19188849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.
    Ladd CO; Newport DJ; Ragan KA; Loughhead A; Stowe ZN
    Depress Anxiety; 2005; 22(2):94-7. PubMed ID: 16094663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison between manual acupuncture and electroacupuncture for hot flashes and sex hormone of perimenopausal syndrome].
    Cao Z; Tang J; Xue Y; Wang Q; Li S; Zhou Y; Zhang W
    Zhongguo Zhen Jiu; 2017 Mar; 37(3):247-252. PubMed ID: 29231429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe hot flashes are associated with chronic insomnia.
    Ohayon MM
    Arch Intern Med; 2006 Jun; 166(12):1262-8. PubMed ID: 16801508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nocturnal Hot Flashes, but Not Serum Hormone Concentrations, as a Predictor of Insomnia in Menopausal Women: Results from the Midlife Women's Health Study.
    Hatcher KM; Smith RL; Chiang C; Flaws JA; Mahoney MM
    J Womens Health (Larchmt); 2023 Jan; 32(1):94-101. PubMed ID: 36450126
    [No Abstract]   [Full Text] [Related]  

  • 29. Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition.
    Freeman MP; Hirschberg AM; Wang B; Petrillo LF; Connors S; Regan S; Joffe H; Cohen LS
    Maturitas; 2013 Jun; 75(2):170-4. PubMed ID: 23602542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between depressive symptoms and reproductive variables in a group of perimenopausal women attending a menopause clinic in México City.
    Flores-Ramos M; Heinze G; Silvestri-Tomassoni R
    Arch Womens Ment Health; 2010 Feb; 13(1):99-105. PubMed ID: 19730981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiety as a risk factor for menopausal hot flashes: evidence from the Penn Ovarian Aging cohort.
    Freeman EW; Sammel MD
    Menopause; 2016 Sep; 23(9):942-9. PubMed ID: 27433864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial.
    Ensrud KE; Joffe H; Guthrie KA; Larson JC; Reed SD; Newton KM; Sternfeld B; Lacroix AZ; Landis CA; Woods NF; Freeman EW
    Menopause; 2012 Aug; 19(8):848-55. PubMed ID: 22433978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of St John's wort on severity, frequency, and duration of hot flashes in premenopausal, perimenopausal and postmenopausal women: a randomized, double-blind, placebo-controlled study.
    Abdali K; Khajehei M; Tabatabaee HR
    Menopause; 2010 Mar; 17(2):326-31. PubMed ID: 20216274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women.
    Johnson TM; Cohen HW; Howard AA; Santoro N; Floris-Moore M; Arnsten JH; Hartel DM; Schoenbaum EE
    Menopause; 2008; 15(3):551-7. PubMed ID: 18188138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy.
    O'Brien SM; Scully P; Fitzgerald P; Scott LV; Dinan TG
    J Psychiatr Res; 2007; 41(3-4):326-31. PubMed ID: 16870211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
    Kornstein SG; Clayton A; Bao W; Guico-Pabia CJ
    Menopause; 2014 Aug; 21(8):799-806. PubMed ID: 24448103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
    Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of a novel extract of fenugreek seeds in alleviating vasomotor symptoms and depression in perimenopausal women: A randomized, double-blinded, placebo-controlled study.
    Khanna A; John F; Das S; Thomas J; Rao J; Maliakel B; Im K
    J Food Biochem; 2020 Dec; 44(12):e13507. PubMed ID: 33025616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women.
    Oppermann K; Fuchs SC; Donato G; Bastos CA; Spritzer PM
    Menopause; 2012 Mar; 19(3):355-60. PubMed ID: 21971211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.